<DOC>
	<DOCNO>NCT02213081</DOCNO>
	<brief_summary>The aim research ass benefit medication ( ulipristal ) alleviation symptom woman chronic , endometriosis-related pelvic pain .</brief_summary>
	<brief_title>Ulipristal Endometriosis-related Pelvic Pain</brief_title>
	<detailed_description>This study ass use medication improve symptom chronic , endometriosis-related pelvic pain among woman achieve relief prior surgical medical treatment .</detailed_description>
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Pelvic Pain</mesh_term>
	<criteria>Diagnosis endometriosis surgical confirmation via laparoscopy perform within 3 year prior study enrollment Englishspeaking reproductiveage woman ( 1850yo ) regular , cyclical menses Treatmentrefractory endometriosis , define persistent recurrent pelvic pain follow one treatment involve surgery and/or hormonal treatment Dysmenorrhea chronic pelvic pain least one week month past 5 month longer Endometrial biopsy intervention Adequate organ marrow function define : leukocyte ≥ 3,000/microliter absolute neutrophil count ≥ 1,500/microliter platelet ≥ 100,000/microliter total bilirubin within normal institutional limit Liver function test ≤ 2.5 X institutional upper limit normal creatinine within normal institutional limit Women childbearing potential must agree use adequate contraception ( hormonal barrier method birth control ; abstinence ) prior study entry , duration study participation , 90 day follow completion therapy . Should woman become pregnant suspect pregnant participating study , inform treat physician immediately . A female childbearing potential woman ( regardless sexual orientation , undergone tubal ligation , remain celibate choice ) meet follow criterion : Has undergone hysterectomy bilateral oophorectomy ; Has naturally postmenopausal least 12 consecutive month ( i.e. , menses time precede 12 consecutive month ) . Ability understand willingness sign write informed consent . Undiagnosed vaginal bleeding Abnormal result endometrial biopsy Presence ovarian cyst ≥ 3 cm Pregnancy Refusal adhere birth control strategy study ( use combination condom vaginal sponge intercourse ulipristal , plus one month onset one month completion ulipristal therapy ) Women take digoxin , dabigatran etexilate due interference ulipristal acetate concentration substance bound plasma protein . Women take moderate potent inducer hepatic metabolism ( e.g . erythromycin , ketoconazole , ritonavir , nefazodone ) . History allergic reaction attribute compound similar chemical biologic composition Ulipristal . Uncontrolled intercurrent illness include , limited , ongoing active pulmonary , cardiac , renal , hepatic thromboembolic disease , infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , psychiatric illness/social situation would limit compliance study requirement .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Endometriosis</keyword>
	<keyword>chronic pelvic pain</keyword>
	<keyword>dysmenorrhea</keyword>
	<keyword>dyschezia</keyword>
	<keyword>bleeding</keyword>
	<keyword>ulipristal</keyword>
	<keyword>progesterone</keyword>
</DOC>